Back
Lixte Biotechnology Holdings 10K Form
Sell
18
LIXT
Lixte Biotechnology Holdings
Last Price:
1.69
Seasonality Move:
2.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LIXT News And Ratings
See the #1 stock for the next 7 days that we like better than LIXT
LIXT Financial Statistics
Sales & Book Value
| Annual Sales: | $200K |
|---|---|
| Cash Flow: | $-819K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.56 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.78000 |
|---|---|
| Net Income (TTM): | $-4.03M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Lixte Biotechnology Holdings Earnings Forecast
Key Lixte Biotechnology Holdings Financial Ratios
- The Selling, General & Administrative Expenses for LIXT have been equal to 377.22% of Gross Profit Margin.
- The Interest Expense is -0.32% of Operating Income.
- Per Share Earnings over the last 19 years have been positive in 8 years.
Lixte Biotechnology Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LIXT |
| Website: | lixte.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LIXT Technical Analysis vs Fundamental Analysis
Sell
18
Lixte Biotechnology Holdings (LIXT)
is a Sell
Is Lixte Biotechnology Holdings a Buy or a Sell?
-
Lixte Biotechnology Holdings stock is rated a Sell
The current Lixte Biotechnology Holdings [LIXT] share price is $1.62. The Score for LIXT is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.